Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial

Nishio, M; Barlesi, F; West, H; Ball, S; Bordoni, R; Cobo, M; Longeras, PD; Goldschmidt, J; Novello, S; Orlandi, F; Sanborn, RE; Szalai, Z; Ursol, G; Mendus, D; Wang, LJ; Wen, XH; McCleland, M; Hoang, T; Phan, S; Socinski, MA

Nishio, M (corresponding author), JFCR, Canc Inst Hosp, Dept Thorac Med Oncol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.

JOURNAL OF THORACIC ONCOLOGY, 2021; 16 (4): 653

Abstract

Introduction: We report the final results of the phase 3 IMpower132 study evaluating atezolizumab plus carboplatin or cisplatin plus pemetrexed (APP) ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索